Erik Jorpes

Q: What Schools Are Affiliated With Erik Jorpes

Erik Jorpes is affiliated with the following schools: Karolinska Institute, University of Helsinki

Erik Jorpes's AcademicInfluence.com Rankings

Erik Jorpes

Philosophy

#8917

Historical Rank

Logic

#4387

Historical Rank

philosophy Degrees

Download Badge

Philosophy

Why Is Erik Jorpes Influential?

(Suggest an Edit or Addition)

According to Wikipedia, Johan Erik Jorpes was a Finnish-born Swedish physician and biochemist. He identified the chemical structure of heparin and developed its clinical applications. Jorpes was the professor of medical chemistry in the Karolinska Institute in Stockholm in 1946–1963.

(See a Problem?)

Erik Jorpes's Published Works

Number of citations in a given year to any of this author's works

Total number of citations to an author for the works they published in a given year. This highlights publication of the most important work(s) by the author

Published Works

Structure of Porcine Cholecystokinin‐Pancreozymin (1968) (423)
Hormonal polypeptides of the upper intestine. (1971) (249)
Cholecystokinin and pancreozymin, one single hormone? (1966) (176)
Structure of porcine secretin. The amino acid sequence. (1970) (169)
Preparation of highly active enterogastrone. (1969) (166)
On the chemistry of heparin. (1935) (139)
On heparin monosulfuric acid. (1948) (124)
On the Biological Activity and Amino Acid Composition of Secretin. (1961) (120)
Isolation of aspartyl-phenylalanine amide from cholecystokinin-pancreozymin. (1967) (97)
Structure of porcine cholecystokinin-pancreozymin. 1. Cleavage with thrombin and with trypsin. (1968) (91)
HEPARIN AS A PROPHYLACTIC AGAINST THROMBOSIS (1941) (89)
Further Purification of Cholecystokinin and Pancreozymin. (1964) (84)
Structure of Porcine Secretin. I. Degradation with Trypsin and Thrombin. Sequence of the Tryptic Peptides. The C-Terminal Residue* (1965) (84)
Amino acid composition and N-terminal amino acid sequence of porcine secretin. (1962) (69)
The fuchsin-sulfurous acid test after periodate oxidation of heparin and allied polysaccharides. (1948) (67)
Secretin and Cholecystokinin (CCK) (1973) (61)
THE LINKAGE OF THE AMINO GROUP IN HEPARIN (1950) (58)
NEUTRALISATION OF ACTION OF HEPARIN BY PROTAMINE (1939) (53)
Secretin, pancreozymin, and cholecystokinin; their preparation and properties. (1959) (51)
The protein component of the erythrocyte membrane or stroma. (1932) (47)
The gastrointestinal hormones, secretin and cholecystokinin-pancreozymin. (1961) (43)
Secretin, Cholecystokinin, Pancreozymin and Gastrin (1973) (42)
The origin and the physiology of heparin; the specific therapy in thrombosis. (1947) (41)
Contemporary developments in the biochemistry of the gastrointestinal hormones. (1967) (41)
Recrystallized insulin for diabetic patients with insulin allergy. (1949) (40)
On the biological assay of secretin. The reference standard. (1966) (40)
Heparin : its chemistry, physiology and application in medicine (1939) (37)
Heparin, its chemistry, pharmacology and clinical use. (1962) (36)
HEPARIN: A MUCOITIN POLYSULFURIC ACID (1937) (36)
The chemistry of heparin. (1942) (29)
The preparation of secretin. (1952) (29)
Heparin: A Mucopolysaccharide and an Active Antithrombotic Drug (1959) (28)
The isolation and chemistry of secretin and cholecystokinin. (1968) (27)
A method for the preparation of gastrin. (1952) (25)
The use of the Sakaguchi reaction for the quantitative determination of arginine. (1932) (22)
On the relationship between the sulphur content and the anticoagulant activity of heparin preparations. (1939) (20)
[Secretin and cholecystokinin]. (1974) (19)
The colorimetric determination of histidine. (1932) (17)
Heparin : in the treatment of thrombosis : an account of its chemistry, physiology and application in medidine (1946) (16)
von Willebrand's disease. (1963) (15)
On the administration of heparin. (1951) (14)
On the pentose polynucleotide of the pancreas. (1934) (14)
Casein hydrolysate; a supplementary food for premature infants. (1946) (14)
Clinical aspects of the gastrointestinal hormones secretin and cholecystokinin. (1969) (13)
THE RATE OF HYDROLYSIS OF RIBONUCLEOTIDES (1929) (13)
Jac Berzelius: His Life and Work (1970) (13)
ON THE RELIABILITY OF THE METHODS USED IN THE ASSAY OF HEPARIN (1953) (12)
aN IN VIVO METHOD FOR THE ASSAY OF HEPARIN (1954) (11)
Studies on pure Heparin1 (1937) (11)
ON THE ASSAY OF THROMBIN PREPARATIONS (1958) (11)
THE EFFECT OF SECRETIN ON BILE FLOW. (1963) (11)
Anticoagulant therapy in thrombosis. (1947) (10)
Preparation and some properties of hypertensin (angiotonin) (1942) (10)
On the biological assay of cholecystokinin and its dosage in cholecystography. (1960) (9)
The blood clotting mechanism. (1956) (8)
On the biological assay of gastrin. (1947) (7)
Studies on the A-antigenic polysaccharide from the abomasus of cattle. (1945) (7)
Purification of Secretin by Freezing out of Impurities from Methanolic Solution at −80° C. (1953) (7)
A New Principle for Large Scale Production of Insulin. (1960) (6)
An application of Pregl's Micro‐Analysis to the Determination of free Phosphates in the Blood. (1927) (6)
On the inhomogeneity of the urinary human A-substance. (1945) (6)
Recent trends in anticoagulant therapy of thrombosis. (1952) (5)
Purification of pancreozymin. (1963) (5)
A METHOD OF SEPARATION OF RIBOPOLYNUCLEOTIDES FROM THYMONUCLEIC ACID AND ON THE CONDITIONS FOR A QUANTITATIVE SEPARATION OF THE PURINE BASES FROM THE RIBOPOLYNUCLEOTIDES (1930) (5)
Is insulin antigenic? (1949) (5)
ON THE STRUCTURE OF MELIBIOSE (1930) (5)
ON THE CHEMICAL COMPOSITION OF THE ISLANDS OF LANGERHANS IN THE MONKFISH (LOPHIUS PISCATORIUS, L.) (1930) (3)
Purified Secretin and Pancreozymin. (1955) (3)
Recrystallized insulin for diabetics with insulin allergy. (1950) (3)
[Biological standardization of heparin]. (1961) (2)
[Cholecystokinin-pancreozymin (CCK-PZ)]. (1967) (2)
Cholecystokinin (CCK) (1970) (2)
THE PHARMACY OF BLOOD, ITS PRODUCTS AND SUBSTITUTES * (1956) (2)
VI – Gastrointestinal Hormones (1964) (2)
On the quantitative determination of adenine in the presence of guanine. (1934) (2)
Molecular architecture of peptide hormones optical rotatory dispersion of cholecystokinin-pancreozymin, bradykinin and 6-glycine bradykinin (1970) (2)
Co-Zymase. VIII. (2)
An Attempt at Isolating the Carbohydrate Moiety of Crystalline Ovalbumin by Means of Cataphoresis (1941) (2)
[Secretin, pancreozymin and cholecystokinin, the silent hormones]. (1960) (1)
Current therapeutics. LXI. Heparin and thrombosis. (1953) (1)
V. Willebrand's disease and its treatment with a specific plasma fraction. (1959) (1)
Chemistry Department of Karolinska Mediko-kirurgiska Institutet in Stockholm 1810-1960. (1960) (1)
[The use of secretin and cholecystokinin-pancreozymin]. (1962) (1)
[Secretin, pancreozymin, and cholecystokinin; their physiology and future clinical use]. (1956) (1)
[Secretin and glucagon as regulators of insulin release into the blood]. (1967) (1)
ISOTOPES IN BIOLOGY AND MEDICINE (1949) (1)
[Recollection of the first heparin era]. (1961) (0)
[Prevention and therapy of thrombosis of the legs]. (1955) (0)
[Hormones in the intestinal wall]. (1967) (0)
[Use of cholecystokinin in cholecystography]. (1957) (0)
[INCUBATION PERIOD OF MEDICAL DISCOVERIES]. (1963) (0)
Questions of current interest in the Swedish medical world. (1947) (0)
EMPTYING OF THE HUMAN GALLBLADDER UNDER THE STIMULUS OF CHOLECYSTOKININ (1958) (0)
An application of Pregl's Micro‐Analysis to the Determination of free Phosphates in the Blood. (1927) (0)
[Secretin]. (1966) (0)
[Gastrointestinal hormones as tools of clinical diagnosis]. (1959) (0)
[When Berzelius worked as a specialist in cholera]. (1967) (0)
[Cholecystokinin (CCK). Physiology and clinical use]. (1970) (0)
[On secretin and cholecystokinin in the diagnosis of pancreatic and bile duct cancer]. (1960) (0)
[Not Available]. (1948) (0)
[Svante Arrhenius--a centennial commemoration]. (1960) (0)
Erratum to: Der oxydative Endabbau (1954) (0)
The history of dicoumarol. (1944) (0)
[Pathophysiology of hemorrhagic conditions]. (1958) (0)
Polysacoharide sulphuric acid esters in the animal kingdom. (1940) (0)
[Determination of the biological strength of thrombin]. (1961) (0)
[In memoriam. Einar Hammarsten. 4-1-1889--16-11-1968]. (1968) (0)
Purification of secretin by freezing out of impurities from methanolic solution at-80 degree C. (1953) (0)
Past and Present in the Use of Secretin and Cholecystokinin-Pancreozymin (1963) (0)
Studies on Blood Coagulation Factor V VI . The fnactivation of Factor V anrl Prothrombinase (0)
[Alfred Nobel-- his formative years and achievements]. (1965) (0)
Whole blood or other clotting systems in assaying heparin. (1946) (0)
The surgeon's cooperation with the biochemist. Some aspects of blood clotting in surgery. (1959) (0)
Questions of current interest in the Swedish medical world. (1946) (0)
[Cholecystokinin in radiography of the bile ducts]. (1957) (0)
[Treatment of hemophilia A with Blombaeck and Blombaeck plasma fraction I-O]. (1962) (0)
Anticoagulant Therapy in Thrombosis (1946) (0)
[THE "INCUBATION TIME" OF MEDICAL DISCOVERIES]. (1963) (0)
[E.A. von WILLEBRAND and von Willebrand's disease]. (1962) (0)
[Heparin for the introduction of contnuous treatment with anticoagulants]. (1964) (0)
[THROMBOEMBOLIC AND HEMORRHAGIC CONDITIONS]. (1963) (0)
Vitamin K and prothrombin formation. (1940) (0)
[Origin and mode of action of cholecystokinin--pancreozymin]. (1969) (0)
[Physiological and clinical aspects of the digestive hormones]. (1968) (0)

This paper list is powered by the following services:

Other Resources About Erik Jorpes

en.wikipedia.org

What Schools Are Affiliated With Erik Jorpes?

Erik Jorpes is affiliated with the following schools:

Erik Jorpes's Academic­Influence.com Rankings